![](https://cyberleninka.org/viewer_images/863435/f/1.png)
CTLA4 as Immunological Checkpoint in the Development of Multiple
![CTLA4 as Immunological Checkpoint in the Development of Multiple](https://pub.mdpi-res.com/genes/genes-13-01319/article_deploy/html/images/genes-13-01319-ag.png?1659082243)
Genes, Free Full-Text
Immune checkpoint analysis, Flow cytometry assays
![CTLA4 as Immunological Checkpoint in the Development of Multiple](https://www.mdpi.com/cancers/cancers-15-02718/article_deploy/html/images/cancers-15-02718-g001.png)
Cancers, Free Full-Text
MORE
![CTLA4 as Immunological Checkpoint in the Development of Multiple](https://www.cell.com/cms/attachment/cb8f8e60-9a4d-44df-a8df-f8cde148c9df/fx1_lrg.jpg)
Natural killer cells and immune-checkpoint inhibitor therapy
![CTLA4 as Immunological Checkpoint in the Development of Multiple](https://www.crownbio.com/hubfs/assets/tim-3.jpg)
What's Next for Immune Checkpoint Inhibitors: TIM-3?
![CTLA4 as Immunological Checkpoint in the Development of Multiple](https://www.mdpi.com/cancers/cancers-13-01440/article_deploy/html/images/cancers-13-01440-g001.png)
Cancers, Free Full-Text
![CTLA4 as Immunological Checkpoint in the Development of Multiple](https://bioxcell.com/wp/wp-content/uploads/2022/09/Immune-pathways-vibrant.jpeg-scaled-1-scaled.jpg)
Immune Checkpoint Antibodies
![CTLA4 as Immunological Checkpoint in the Development of Multiple](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrc3239/MediaObjects/41568_2012_Article_BFnrc3239_Fig1_HTML.jpg)
The blockade of immune checkpoints in cancer immunotherapy
![CTLA4 as Immunological Checkpoint in the Development of Multiple](https://www.mdpi.com/cancers/cancers-14-01580/article_deploy/html/images/cancers-14-01580-g001.png)
Cancers, Free Full-Text
![CTLA4 as Immunological Checkpoint in the Development of Multiple](https://d2akihtr51eb46.cloudfront.net/wp-content/uploads/2019/04/CI.jpg)
CHECKPOINT INHIBITORS - Novel Targets & Global Markets
![CTLA4 as Immunological Checkpoint in the Development of Multiple](https://ars.els-cdn.com/content/image/1-s2.0-S1043661821005818-ga1.jpg)
Clinical experience with CTLA-4 blockade for cancer immunotherapy
![CTLA4 as Immunological Checkpoint in the Development of Multiple](https://ars.els-cdn.com/content/image/1-s2.0-S266637912030210X-fx1.jpg)
Development and Preliminary Clinical Activity of PD-1-Guided CTLA
![CTLA4 as Immunological Checkpoint in the Development of Multiple](https://onlinelibrary.wiley.com/cms/asset/7132acda-f179-4ced-9d3d-381f06527801/eji4980-fig-0001-m.jpg)
Combined anti‐PD‐1 and anti‐CTLA‐4 checkpoint blockade: Treatment
![CTLA4 as Immunological Checkpoint in the Development of Multiple](https://www.spandidos-publications.com/article_images/ol/20/4/ol-20-04-11909-g01.jpg)
Current progress and prospect of immune checkpoint inhibitors in
![CTLA4 as Immunological Checkpoint in the Development of Multiple](https://www.science.org/cms/10.1126/science.aar4060/asset/834600b7-d2fa-4034-9a01-8d410c9b60fc/assets/graphic/359_1350_f1_v2.jpeg)
Cancer immunotherapy using checkpoint blockade